Haefliger J M, Alberto P
Schweiz Med Wochenschr. 1977 Oct 22;107(42):1492-6.
A retrospective study on the survival of 99 patients with ovarian carcinoma stages I-IV has been conducted. A bad prognosis for early stages is emphasized. 38 of the 64 patients treated by chemotherapy presented an objective therapeutic response: 24 cases showed complete or partial remission of a duration between 4 to 26 months, while 14 cases showed no change or progressive disease. The effects of chemotherapy on survival have been statistically analyzed for these 38 cases and have shown a longer survival for responders. These results suggest that the use of chemotherapy as an adjuvant to surgery in ovarian cancer deserves further investigation.
